Want to create an interactive transcript for this episode?
Podcast: Supreme Court Decision Syllabus (SCOTUS Podcast)
Episode: FDA v. Alliance for Hippocratic Medicine (Birth Control)
Description: Send us Fan MailFDA v. Alliance for Hippocratic MedicineIn 2000, the Food and Drug Administration approved a new drug application for mifepristone tablets marketed under the brand name Mifeprex for use in terminating pregnancies up to seven weeks. To help ensure that Mifeprex would be used safely and effectively, FDA placed additional restrictions on the drug’s use and distribution, for example requiring doctors to prescribe or to supervise prescription of Mifeprex, and requiring patients to have three in-person visits with the doctor to receive the drug. In 2016, FDA relaxed some of th...